Name: Latest research reports of Anuh Pharma Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Anuh Pharma Ltd.
Rating: 5
Author: Motilal Oswal

Anuh Pharma Ltd.

BSE: 506260

Mid-range Performer

Download real time

173.65 2.10 (1.22%)

33.47% Fall from 52W High

36,097 NSE+BSE Volume

BSE 21 Apr, 2025 4:01 PM (IST)

870.2

Market Cap

Above industry Median

0.9

Beta 1Year

Low volatility

Keep track of all breaking news on Anuh Pharma Ltd. from all sources in a single place.

Anuh Pharma Ltd.

30 May 2016

173.65

1.22%

Results Overview- Below ests; Disappointment on all counts; EDQM ruli

Buy: Anuh Pharma Ltd.

Motilal Oswal

In its bid to add new high value products, Anuh has been developing new APIs which have recently gone off patent (post 2014 or which are likely to go off patent in the future). These new APIs will have much higher margins compared to the existing basket. Anuh currently has 20 products in the pipeline of which 4 would be launched in...

Anuh Pharma Ltd. is trading below its 100 day SMA of 189.7

Is Anuh Pharma Ltd. worth buying?

225 Votes:

Buy 72.89%

Sell 10.67%

Hold 16.44%

33.47% Fall from 52W High

Anuh Pharma Ltd. News and Updates

Keep track of all breaking news on Anuh Pharma Ltd. from all sources in a single place.